Parse Biosciences Launches the Next Generation of its Immune Profiling Kits
Summary
Parse Biosciences launched the next generation of its Evercode TCR and Evercode BCR immune profiling kits and started shipping them worldwide. The updated kits improve sensitivity, receptor recovery, and whole transcriptome library efficiency for single-cell immune repertoire studies. The company says the new v4 chemistry unifies immune repertoire and transcriptomic workflows on a single platform. Researchers studying autoimmunity, cancer immunotherapy, and other immune responses now have a higher-performance tool for large-scale studies.
Classifications
industries
No industries detected
applications
Data Management
AskAI Classifications
Labels
SaaS
Bioinformatics Software
Scientific Data Analytics
Linked Companies
Parse Biosciences
$10M to $25M